"Indi's Series B represents our investors and management's belief Xpresys Lung has the potential to achieve blockbuster status," said
As part of the financing,
"We are very pleased to help Indi take their early commercial success with Xpresys Lung to the next level," said Liang. "Indi has taken their innovative proteomic technology and applied it to a massive unmet need: the high costs associated with over-diagnosing lung nodules. Their strategy is a perfect fit for
Data from two studies supporting the technology behind Xpresys Lung were published in Science Translational Medicine on
"We believe Xpresys Lung will play a significant role in helping physicians more effectively manage lung nodules -- and Indi's technology for blood-based diagnostics has the potential to become an important tool in multiple areas of health care," said
Today, it is estimated millions of pulmonary nodules are discovered each year; after traditional assessment protocols, which include biopsies and surgeries, most of these nodules are classified as benign. Xpresys Lung allows for the non-invasive assessment of pulmonary nodules in the 8-30 mm size range; traditionally, nodules of this size are associated with significant diagnostic uncertainty. Xpresys Lung provides physicians with objective information to identify nodules with a high probability of being benign, potentially reducing unnecessary invasive procedures that may be risky for the patient and costly to the healthcare system. In developing the test, researchers at Indi followed an innovative strategy: Xpresys Lung is designed only to assist physicians in identifying lung nodules likely to be benign, and is not intended to assist physicians with the identification of lung cancer.
The blood test measures the relative abundance of proteins from multiple pathways associated with lung cancer, using a highly sensitive analytic technique called multiple reaction monitoring mass spectroscopy (MRM-mass spec) (see also Proteomics).
Keywords for this news article include: Proteomics, Technology.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- National Retail Federation Reduces Sales Forecast
- Amazon Hiring on Calif.'s Central Coast
- Sporty Ford Fiesta Fires on All 3 Cylinders
- Prison Workers Wanted
- Pandora Tumbles in Late Trading
- Jennifer Lopez Throws Big Bash for Birthday
- Small Firms Take Out the Trash in Jersey
- Citigroup Unit Paying $5 Million to Settle SEC Charges
- Execs Help Entrepreneurs, Get Chevy Volts
- Obama Seeks Help From Central American Leaders